ROSS 10-K & 10-Q changes, risk factors and insider trading
BPGC Acquisition Corp. · Blank Checks · CIK 1841610 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
New heading “Risks Relating to Our Business and the Initial Business Combination”
Largest changes
“Additionally, the Company was unable to timely file the periodic financial reports required under the Exchange Act. The Company filed the Original Comprehensive Form 10-K for the year ended December 31, 2024 as well as the interim period financial statements for March 31, 2024, June 30, 2024, September 30, 2024, March 31, 2025 and June 30, 2025 beyond their required due dates. …”see in full comparison
During the course of preparing the Quarterly Report on Form 10-Q for the three and six months ended June 30, 2023, we identified a waiver of deferred underwriter commissions which was executed during the three months ended March 31, 2023 and not accounted for. In January 2023, we received a waiver from one of the underwriters in which it indicated that it waived its entitlement to the payment of any deferred discount to be paid under the terms of the underwriting agreement. The Company determined this error was material to the Quarterly Report on Form 10-Q for the three months ended March 31, 2023, as further discussed in our Quarterly Report on Form 10-Q for the period ended June 30, 2023, under Note 2 to the Financial Statements – Restatement to Prior Period Financial Statements. As part of such process, the Company identified a material weakness in its internal controls over financial reporting related to ineffective review controls over thesee in full comparisonaccountingconsolidatedtreatmentfinancial statement preparation process including the review ofcertainnewfeesagreements,waivedwhichbyled to theunderwritersrestatement of theCompany’sspecifiedInitialfinancialPublic Offering.statements.
“Risks Relating to Our Business and the Initial Business Combination”see in full comparison
see in full comparisonRisks RelatingAlthoughto Our Business and the Initial Business Combination Althoughwe intend to seek shareholder approval in connection with the Proposed Business Combination, our shareholders may not be afforded an opportunity to vote on another proposed Initial Business Combination, and even if we seek shareholder approval, our Sponsor owns enough shares to assure approval of any related proposal, which means we may complete the Proposed Business Combination or another Initial Business Combination, even though a majority of our shareholders do not support such a combination.
If we do not complete the Proposed Business Combination and instead seek to complete another Initial Business Combination, we may seek to enter into an Initial Business Combination agreement with a prospective target that requires as a closing condition that we have a minimum net worth or a certain amount of cash. In connection with the Firstsee in full comparisonExtraordinary GeneralExtension Meeting, shareholders holding 28,119,098 Public Shares exercised their right to redeem such shares for a pro rata portion of the funds held in our Trust Account as of March 9, 2023, including any interest earned on the funds held in the Trust Account (net of taxes payable). As a result, approximately $287.7 million (approximately $10.23 per share) was removed from the Trust Account to pay such holders. In connection with the SecondExtraordinaryExtensionGeneralMeeting, shareholders of 1,339,804 Public Shares of the Company properly exercised their right to redeem their Public Shares for cash at a redemption price of approximately $10.74 per share, for an aggregate redemption amount of approximately $14.4 million. In connection with the Third Extension Meeting, shareholders of1,339,8042,372,565 Public Shares of the Company properly exercised their right to redeem their Public Shares for cash at a redemption price of approximately$10.74$11.02 per share, for an aggregate redemption amount of approximately$14.4$26.2 million. In connection with theThirdFourthExtraordinaryExtensionGeneralMeeting, shareholders of2,372,5652,512,919 Public Shares of the Company properly exercised their right to redeem their Public Shares forcash at a redemption price of approximately $11.02 per share, for an aggregate redemption amount of approximately $26.2 million. In connection with the Fourth Extraordinary General Meeting, shareholders of 2,512,919 Public Shares of the Company properly exercised their right to redeem their Public Shares forcash at a redemption price of approximately $11.50 per share, for an aggregate redemption amount of approximately $28.9 million. In connection with the Fifth Extraordinary General Meeting, shareholders of 45,195 Public Shares of the Company properly exercised their right to redeem their Public Shares for cash at a redemption price of approximately $12.07 per share, for an aggregate redemption amount of approximately $545 thousand. Following the aforementioned redemptions, as of March 30, 2026, we had8,780,6144,435,419 ordinary shares outstandingas of November 28, 2025,which includes4,455,614110,419 Class A Ordinary Shares, all of which155,614are Public Shares, and 4,325,000 Class B Ordinary Shares, and 430,000 Preference Shares. As a result of such redemptions, approximately$1,860,032$1.3 million remains in the Trust Account as ofOctoberMarch31,30,2025.2026. As a result, we would not be able to meet such closing condition unless we were able to obtain additional financing in connection with such Initial Business Combination.
We offered our Units at an offering price of $10.00 per Unit and, as ofsee in full comparisonOctoberMarch31,30,2025,2026, the amount in our Trust Account was approximately$1.86$1.3 million, implying a value of approximately$11.95$12.07 per Public Share. However, prior to our Public Offering, our Sponsor paid a nominal aggregate purchase price of $25,000 for the Founder Shares, or approximately $0.003 per share, and on March 15, 2024, pursuant to the Class A Conversion, our Sponsor converted 4,300,000 Class B ordinary shares into an equal number of Class A Conversion Shares. Our Sponsor agreed to waive its redemption rights with respect to such Class A Conversion Shares in connection with a shareholder vote to approve an Initial Business Combination (including the Proposed Business Combination) and its right to receive any distribution from the Trust Account with respect to such Class A Conversion Shares. On February 13, 2026, the Sponsor surrendered to the Company, for no consideration, the 4,300,000 Class A Conversion Shares. Also on February 13, 2026, the Sponsor purchased 430,000 Preference Shares. Our Sponsor agreed to waive any redemption rights with respect to such Preference Shares in connection with a shareholder vote to approve an Initial Business Combination (including the Proposed Business Combination) and any right to receive any distribution from the Trust Account with respect to such Preference Shares. Each Preference Share will convert into ten Class A Ordinary Shares immediately prior to, concurrently with, or immediately filing closing of an Initial Business Combination, including the Proposed Business Combination. As a result, the value of our Public Shareholders’ Public Shares may be significantly diluted upon the consummation of the Proposed Business Combination or another Initial Business Combination, when the remaining Founder Shares and Preference Shares are converted into Class A Ordinary Shares. For example, the following table shows the dilutive effect of the Founder Shares and theClass A ConversionPreference Shares on the implied value of the Public Shares that remain outstanding following the Fourth Extension upon the consummation of the Proposed Business Combination or another Initial Business Combination assuming that our equity value at that time is$1,860,032,$1,332,638, which is the approximate amount we would have for the Proposed Business Combination or another Initial Business Combination in the Trust Account assuming no further interest is earned on the funds held in the Trust Account, no additional extension payments are made into the Trust Account and none of the remaining Public Shares are redeemed in connection with the Proposed Business Combination or such other Initial Business Combination, and without taking into account any other potential impacts on our valuation at such time, such as the trading price of our Public Shares, the business combination transaction costs, any equity issued or cash paid to the target’s sellers or other third parties, or the target’s business itself, including its assets, liabilities, management and prospects, as well as the value of our Public Warrants and Private Placement Warrants. At such valuation, each of our ordinary shares would have an implied value of approximately$0.21$0.15 per share upon consummation of the Proposed Business Combination or another Initial Business Combination, which is a97.9%98.5% decrease as compared to the initial implied value per Public Share of $10.00.
Full comparison: every changed paragraph (45)
We
failed to timely file our
periodic reports in accordance with the rules of the SEC for the years ended December 31, 2023 and 2024, nor
for the quarterly periods
ended March 31, 2024, June 30, 2024, September 30, 2024, March 31, 2025 and2025, June 30, 2025 and September 30, 2025.
ThisOn November 27, 2025, we filed
Comprehensivea comprehensive annual report on Form 10-K isfor beingthe fiscal years ended December 31, 2023 and 2024 and the quarterly periods ended March
31, 2024, June 30, 2024, September 30, 2024, March 31, 2025 and June 30, 2025 (the “Original Comprehensive 10-K”).
We subsequently amended the Original Comprehensive 10-K on January 7, 2026 (as amended, the “Comprehensive 10-K”).
We filed our quarterly report for the quarterly period ended September 30, 2025 on January 7, 2025. Each of such filings were made in
an effort to become current in our filing obligations under the Exchange Act. Our efforts to
become and remain current requirehave required,
and will continue to require, substantial management time and attention as well as additional accounting and legal expense. In addition,
if if
we are unable to becomeremain current in our filings with the SEC, we may face several adverse consequences. If we are unable to remain current
in our filings with the SEC, investors in our securities will not have information regarding our business and financial condition with
which to make decisions regarding investment in our securities. In addition, we will not be able to have a registration statement under
the Securities Act covering a public offering of securities declared effective by the SEC and will not be able to make offerings pursuant
to existing registration statements pursuant to certain “private placement” rules of the SEC under Regulation D to any purchasers
not qualifying as “accredited investors.” These restrictions could adversely affect our business, financial condition and
results of operations.
We
will not apply to quote our securities on an over-the-counter market until we have filed all reports required to be filed with the SEC
and we will not apply to relist
our securities on a national securities exchange until we have completed the Proposed Business Combination
or another Initial Business
Combination, if at all. This Comprehensive Form 10-K is being filed in an effort for us to become current
in our filing obligations under the Exchange Act. There can be no assurance that we will be able to obtain listing of our securities
on a national securities exchange.
We may decide it is not in our stockholders’ best interests to apply for a listing on a national
securities exchange once we become current with our SEC reporting requirements.exchange.
Further,
the National Securities
Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating
the sale of certain securities,
which are referred to as “covered securities.” The Company’s Class A Ordinary Shares,
Units and Warrants have ceased
to qualify as covered securities under such statute because they are no longer listed on any national
securities exchange. Accordingly,
we and our securities are subject to state regulation in each state in which we offer our securities.
Whether or not our securities are
covered securities, the states have the power to investigate companies if there is a suspicion of fraud,
and, if there is a finding of
fraudulent activity, then the states can regulate or bar the sale of covered securities in a particular
case. While we are not aware of
a statestate, except the State of Idaho, having used these powers to prohibit or restrict the sale of securities issued by special purpose
acquisition companies, certain state securities regulators view blank check companies unfavorably and might use these powers, or threaten
to use these powers, to hinder the sale of securities of blank check companies in their states. This risk may be exacerbated by the fact
that our securities have ceased to qualify as covered securities.
During the course of preparing
the Quarterly Report on Form 10-Q for the three and six months ended June 30, 2023, we identified a waiver of deferred underwriter commissions
which was executed during the three months ended March 31, 2023 and not accounted for. In January 2023, we received a waiver from one
of the underwriters in which it indicated that it waived its entitlement to the payment of any deferred discount to be paid under the
terms of the underwriting agreement. The Company determined this error was material to the Quarterly Report on Form 10-Q for the three
months ended March 31, 2023, as further discussed in our Quarterly Report on Form 10-Q for the period ended June 30, 2023, under Note
2 to the Financial Statements – Restatement to Prior Period Financial Statements. As part of such process, the Company identified
a material weakness in its internal controls over financial reporting related to ineffective review controls over the accountingconsolidated treatmentfinancial
statement preparation process including the review of certainnew feesagreements, waivedwhich byled to the
underwriters restatement of the Company’sspecified Initialfinancial Public Offering.statements.
Additionally, the Company was unable to timely file the periodic financial reports required under the Exchange Act. The Company filed the Original Comprehensive Form 10-K for the year ended December 31, 2024 as well as the interim period financial statements for March 31, 2024, June 30, 2024, September 30, 2024, March 31, 2025 and June 30, 2025 beyond their required due dates. Further, on January 6, 2026, our audit committee, in consultation with our management, concluded that the Company’s audited financial statements for the year ended December 31, 2024, and unaudited quarterly financial information for the quarterly periods ended March 31, 2024, June 30, 2024, September 30, 2024, March 31, 2025 and June 30, 2025, each as set forth in the Original Comprehensive Form 10-K, should no longer be relied upon because they did not properly reflect the 2024 Conversion by the Sponsor. The material weakness in internal controls over financial reporting related to ineffective review controls over the consolidated financial statement preparation process including the review of new agreements, led to the restatement of the financial statements for the Restated Periods.
Additionally, the Company
was unable to timely file the periodic financial reports required under the Exchange Act. The Company is filing this Form 10-K for the
year ended December 31, 2024 as well as the interim period financial statements for March 31, 2025 and June 30, 2025 beyond their required
due dates.
As
a result of this material
weakness, our management concluded that our internal control over financial reporting was not effective as
of December 31, 2023, December
31, 2024 and December 31, 2024.2025.
Risks Relating to Our Business and the Initial Business Combination
Risks
RelatingAlthough to Our Business and the Initial Business Combination Although
we intend to seek shareholder approval
in connection with the Proposed Business Combination, our shareholders may not be afforded an
opportunity to vote on another proposed
Initial Business Combination, and even if we seek shareholder approval, our Sponsor owns enough
shares to assure approval of any related
proposal, which means we may complete the Proposed Business Combination or another Initial Business
Combination, even though a majority
of our shareholders do not support such a combination.
Our
Sponsor owns, on an as-converted
basis, approximately 98.2%97.5% of our outstanding ordinary shares. Our Sponsor and members of our management
team also may from time to time
purchase Public Shares prior to our Initial Business Combination. Our Charter provides that, if we seek
shareholder approval, we will
complete the Proposed Business Combination or another Initial Business Combination only if a majority of
the ordinary shares, represented
in person or by proxy and entitled to vote thereon, voted at a shareholder meeting are voted in favor
of the applicable Initial Business
Combination. Following the redemptions in connection with the Extensions, we have 8,780,614]4,435,419 ordinary
shares outstanding, which includes 4,455,614
110,419 Class A Ordinary Shares, all of which 155,614 are Public Shares, and 4,325,000 Class B Ordinary Shares and 430,000 Preference Shares.
Shares. As a result, we will not need any of the remaining Public Shares sold in the Initial Public Offering to be voted in favor of
the Proposed
Business Combination or another Initial Business Combination in order to have our Initial Business Combination approved. Accordingly,
Accordingly, if we seek shareholder approval of our Initial Business Combination, as we expect to do in connection with the Proposed
Business Combination,
the agreement by our Sponsor and each member of our management team to vote in favor of the Proposed Business Combination
or another Initial
Business Combination means that we will receive the requisite shareholder approval for the Proposed Business Combination
or such other
Initial Business Combination.
If we do not complete the
Proposed Business Combination and instead seek to complete another Initial Business Combination, we may seek to enter into an Initial
Business Combination agreement with a prospective target that requires as a closing condition that we have a minimum net worth or a certain
amount of cash. In connection with the First Extraordinary GeneralExtension Meeting, shareholders holding 28,119,098 Public Shares exercised their
right to
redeem such shares for a pro rata portion of the funds held in our Trust Account as of March 9, 2023, including any interest
earned on
the funds held in the Trust Account (net of taxes payable). As a result, approximately $287.7 million (approximately $10.23
per share)
was removed from the Trust Account to pay such holders. In connection with the Second ExtraordinaryExtension GeneralMeeting, shareholders of 1,339,804 Public
Shares of the Company properly exercised their right to redeem their Public Shares for cash at a redemption price of approximately $10.74
per share, for an aggregate redemption amount of approximately $14.4 million. In connection with the Third Extension Meeting, shareholders
of 1,339,8042,372,565 Public Shares of the Company properly exercised their right to redeem their Public Shares for cash at a redemption price
of approximately $10.74$11.02 per share, for an aggregate redemption amount of approximately $14.4$26.2 million. In connection with the ThirdFourth ExtraordinaryExtension
General Meeting, shareholders of 2,372,5652,512,919 Public Shares of the Company properly exercised their right to redeem their Public Shares for
cash at a redemption price of approximately $11.02 per share, for an aggregate redemption amount of approximately $26.2 million. In connection
with the Fourth Extraordinary General Meeting, shareholders of 2,512,919 Public Shares of the Company properly exercised their right to
redeem their Public Shares for cash
at a redemption price of approximately $11.50 per share, for an aggregate redemption amount of approximately
$28.9 million. In connection
with the Fifth Extraordinary General Meeting, shareholders of 45,195 Public Shares of the Company properly exercised their right to redeem
their Public Shares for cash at a redemption price of approximately $12.07 per share, for an aggregate redemption amount of approximately
$545 thousand. Following the aforementioned redemptions, as of March 30, 2026, we
had 8,780,6144,435,419 ordinary shares outstanding as of November 28, 2025, which includes
4,455,614 110,419 Class A Ordinary Shares, all of which 155,614 are Public Shares, and 4,325,000
Class B Ordinary Shares, and 430,000 Preference Shares. As a result of such redemptions,
approximately $1,860,032$1.3 million remains in the Trust
Account as of OctoberMarch 31,30, 2025.2026. As a result, we would not be able to meet such closing condition
unless we were able to obtain additional
financing in connection with such Initial Business Combination.
At the time we enter into
an agreement for our Initial Business Combination, we will not know how many shareholders may exercise their redemption rights, and therefore
will need to structure the transaction based on our expectations as to the number of shares that will be submitted for redemption. Following
the redemptions in connection with the Extensions, weas hadof 8,780,614March 30, 2026, 4,435,419 ordinary shares outstanding as of November 28, 2025, which includes 110,419
4,455,614 Class A Ordinary Shares, all of which 155,614 are Public Shares, and 4,325,000 Class B Ordinary Shares, and 430,000 Preference Shares. Because
of the limited amount
of cash remaining our Trust Account following the Extensions, we may need to arrange for additional third-party
financing. Raising additional
third-party financing may involve dilutive equity issuances or the incurrence of indebtedness at higher
than desirable levels. The above
considerations may limit our ability to complete the most desirable Initial Business Combination available
to us or optimize our capital
structure. The amount of the deferred underwriting commissions payable to the underwriters, if any, will
not be adjusted for any shares
that are redeemed in connection with an Initial Business Combination.
Although the Merger Agreement
with iRocket does not include a minimum cash condition, if we do not complete the Proposed Business Combination and the definitive agreement
for another Initial Business Combination requires us to use a portion of the cash in the Trust Account to pay the purchase price, or requires
us to have a minimum amount of cash at closing, the probability that our Initial Business Combination would be unsuccessful is increased.
This risk is magnified because, following the redemptions in connection with the Extensions, as of OctoberMarch 31,30, 2025,2026, we had a balance
in cash held in trust of approximately $1.86$1.3 million. If an Initial Business Combination is unsuccessful, shareholders would not receive
their pro rata portion of the funds in the Trust Account until we liquidate the Trust Account. If shareholders are in need of immediate
liquidity, they could attempt to sell their shares in the open market; however, at such time our shares may trade at a discount to the
pro rata amount per share in the Trust Account. Moreover, our securities have been delisted from NYSE and are not quoted on the over-the-counter
market, and therefore, there is currently no public tradable market for our shares. In either situation, shareholders may suffer a material
loss on their investment or lose the benefit of funds expected in connection with our redemption until we liquidate or they are able to
sell their shares in the open market.
If
we do not complete the Proposed Business
Combination, the requirement that we consummate an Initial Business Combination by MarchSeptember 16,
2026 may give potential target businesses
leverage over us in negotiating an Initial Business Combination and may limit the time we have
in which to conduct due diligence on potential
Initial Business Combination targets, in particular as we approach our dissolution deadline,
which could undermine our ability to complete
our Initial Business Combination on terms that would produce value for our shareholders.
If
we do not complete the
Proposed Business Combination with iRocket, any potential target business with which we enter into negotiations
concerning an Initial
Business Combination will be aware that we must consummate an Initial Business Combination by MarchSeptember 16, 2026. Consequently,
such target
business may obtain leverage over us in negotiating an Initial Business Combination, knowing that if we do not complete our
Initial Business
Combination with that particular target business, we may be unable to complete our Initial Business Combination with
any target business.
This risk will increase as we get closer to the time frame described above. In addition, we may have limited time
to conduct due diligence
and may enter into our Initial Business Combination on terms that we would have rejected upon a more comprehensive
investigation.
We
may not be able to complete the Proposed
Business Combination or another Initial Business Combination by MarchSeptember 16, 2026, in which case
we may be required to
cease all operations except for the purpose of winding up and we would redeem our Public Shares and liquidate.
Our
Charter provides that
we must complete the Proposed Business Combination or another Initial Business Combination by MarchSeptember 16, 2026. We
may not be able to
complete the Proposed Business Combination, or if we do not complete the Proposed Business Combination and instead
seek to complete another
Initial Business Combination, find a suitable target business and consummate such Initial Business Combination
by MarchSeptember 16, 2026.
Our ability to complete the Proposed Business Combination or find another Initial Business Combination may be negatively
impacted by general
market conditions, volatility in the capital and debt markets and the other risks described herein. For example,
increased market volatility,
decreased market liquidity and third-party financing being unavailable on terms acceptable to us or at all
could limit our ability to
complete the Proposed Business Combination or another Initial Business Combination. Additionally, financial
markets may be adversely affected
by events outside of our control, including natural disasters, international trade policies, climate-related
events, pandemics or health
crises, current or anticipated military conflict, including between Russia and Ukraine and between Israel
and Hamas, terrorism, sanctions
or other geopolitical events globally.
There
are no assurances that the FourthFifth Extension
will enable us to complete the Proposed Business Combination or another Initial Business
Combination.
Although
the FourthFifth Extension
was approved and implemented, the Company can provide no assurances that the Proposed Business Combination or another
Initial Business
Combination will be consummated prior to the FourthFifth Extended Date. Our ability to consummate the Proposed Business Combination
or another
Initial Business Combination is dependent on a variety of factors, many of which are beyond our control. The Company expects
to seek shareholder
approval of the Proposed Business Combination or any other Initial Business Combination. We were required to offer
Public Shareholders
the opportunity to redeem Public Shares in connection with the Extensions, and we will be required to offer Public
Shareholders redemption
rights again in connection with any shareholder vote to approve the Proposed Business Combination or any other
Initial Business Combination.
If we do not complete the Proposed Business Combination and instead seek to complete another Initial Business
Combination, it is possible
that the high redemptions we have experienced have left us with insufficient cash to consummate another Initial
Business Combination on
commercially acceptable terms, or at all. The fact that we will have had separate redemption periods in connection
with the Extensions
and any Initial Business Combination vote could exacerbate these risks. Other than in connection with a redemption
offer or liquidation,
our shareholders may be unable to recover their investment except through sales of our shares on the open market.
The price of our shares
may be volatile, and there can be no assurance that shareholders will be able to dispose of our shares at favorable
prices, or at all.
We
are a “blank check”
company under the U.S. securities laws. However, because we had net tangible assets in excess of $5,000,000
following consummation of
the Initial Public Offering, we were exempt from rules promulgated by the SEC to protect investors in blank
check companies, such as Rule 419].
419. Accordingly, investors are not afforded the benefits or protections of those rules. Among other things,
this means we will have a
longer period of time to complete an Initial Business Combination than companies subject to Rule 419. Moreover,
if the Initial Public
Offering had been subject to Rule 419, that rule would prohibit the release of any interest earned on funds held
in the Trust Account
to us unless and until the funds in the Trust Account were released to us in connection with our completion of the
Proposed Business Combination
or another Initial Business Combination.
We expect to encounter intense
competition from other entities having a business objective similar to ours, including private investors (which may be individuals or
investment partnerships), other special purpose acquisition companies, the vast majority of which are listed on a national securities
exchange, and other entities, domestic and international, competing for the types of businesses we intend to acquire. Many of these individuals
and entities are well established and have extensive experience in identifying and effecting, directly or indirectly, acquisitions of
companies operating in or providing services to various industries. Many of these competitors possess greater technical, human and other
resources or more local industry knowledge than we do and our financial resources will be relatively limited when contrasted with those
of many of these competitors. While we believe there are numerous target businesses, including iRocket, we could potentially acquire with
the remaining net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, our ability to compete with
respect to the acquisition of certain target businesses that are sizable will be limited by our available financial resources. This risk
is magnified because, following the redemptions in connection with the Extensions, as of OctoberMarch 31,30, 2025,2026, we had a balance in cash
and and
investments held in trust of approximately $1.86$1.3 million. This inherent competitive limitation gives others an advantage in pursuing
the acquisition of certain target businesses. Furthermore, we are obligated to offer holders of our Public Shares the right to redeem
their shares for cash at the time of our Initial Business Combination, including the Proposed Business Combination, in conjunction with
a shareholder vote or via a tender offer. Target companies, such as iRocket, will be aware that this may reduce the resources available
to us for our Initial Business Combination. Any of these obligations may place us at a competitive disadvantage in successfully negotiating
a business combination. If we have not consummated the Proposed Business Combination or another Initial Business Combination within the
required time period, our Public Shareholders may receive only approximately $10.00 per Public Share, or less in certain circumstances,
on the liquidation of our Trust Account and our Warrants will expire worthless. See “—If third parties bring claims against
us, the proceeds held in the Trust Account could be reduced and the per-share redemption amount received by shareholders may be less than
$10.00 per Public Share” and other risk factors herein.
Because
the remaining net proceeds of the
Initial Public Offering and the sale of the Private Placement Warrants not being held in the Trust
Account are insufficient to allow us
to operate until at least MarchSeptember 16, 2026, we may be unable to complete the Proposed Business Combination
or another Initial Business
Combination, and we will depend on loans from our Sponsor, its affiliates or members of our management team
to fund our search and to
complete the Proposed Business Combination or another Initial Business Combination.
None
of the net proceeds of
the Initial Public Offering and the sale of the Private Placement Warrants are available to us outside the Trust
Account to fund our working
capital requirements. We believe that the funds available to us outside of the Trust Account, together with
funds available from loans
from our Sponsor, its affiliates or members of our management team, will be sufficient to allow us to operate
for at least until March September
16, 2026; however, we cannot assure investors that our estimate is accurate, and our Sponsor, its affiliates
or members of our management
team are under no obligation to advance funds to us in such circumstances, except as provided by the Convertible
Note. Of the funds available
to us, we expect to use a portion of the funds available to us to pay fees to consultants to assist us with
our search for a target business.
We could also use a portion of the funds as a down payment or to fund a “no-shop” provision
(a provision in letters of intent
designed to keep target businesses from “shopping” around for transactions with other companies
or investors on terms more
favorable to such target businesses) with respect to a particular Initial Business Combination, although we
have not done so in connection
with the Proposed Business Combination. If we entered into a letter of intent where we paid for the right
to receive exclusivity from
a target business and were subsequently required to forfeit such funds (whether as a result of our breach
or otherwise), we might not
have sufficient funds to continue searching for, or conduct due diligence with respect to, a target business.
Examples
of possible instances
where we may engage a third party that refuses to execute a waiver include the engagement of a third-party consultant
whose particular
expertise or skills are believed by management to be significantly superior to those of other consultants that would
agree to execute
a waiver or in cases where management is unable to find a service provider willing to execute a waiver. In addition,
there is no guarantee
that such entities will agree to waive any claims they may have in the future as a result of, or arising out of,
any negotiations, contracts
or agreements with us and will not seek recourse against the Trust Account for any reason. Upon redemption
of our Public Shares, if we
have not consummated an Initial Business Combination by MarchSeptember 16, 2026, or upon the exercise of a redemption
right in connection with
the Proposed Business Combination or another Initial Business Combination, we will be required to provide for
payment of claims of creditors
that were not waived that may be brought against us within the ten years following redemption. Accordingly,
the per-share redemption amount
received by Public Shareholders could be less than the $10.00 per Public Share initially held in the
Trust Account, due to claims of such
creditors. In order to protect the amounts held in the Trust Account, our Sponsor has agreed that
it will be liable to us if and to the
extent any claims by a third party for services rendered or products sold to us (other than our
independent registered public accounting
firm), or a prospective target business with which we have discussed entering into a transaction
agreement, reduce the amounts in the
Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per
Public Share held in the Trust Account
as of the date of the liquidation of the Trust Account if less than $10.00 per Public Share due
to reductions in the value of the trust
assets, in each case net of the interest that may be withdrawn to pay our tax obligations, provided
that such liability will not
apply to any claims by a third party or prospective target business that executed a waiver of any and all
rights to seek access to the
Trust Account nor will it apply to any claims under our indemnity of the underwriters of the Initial Public
Offering against certain liabilities,
including liabilities under the Securities Act. In the event that an executed waiver is deemed
to be unenforceable against a third-party,
our Sponsor will not be responsible to the extent of any liability for such third-party claims.
In the adopting release for
the 2024 SPAC Rules (as defined below), the SEC provided guidance that a SPAC’s potential status as an “investment company”
depends on a variety of factors, such as a SPAC’s duration, asset composition, business purpose and activities and “is a question
of facts and circumstances” requiring individualized analysis. If we were deemed to be an unregistered investment company and subject
to compliance with and regulation under the Investment Company Act, we would be subject to additional regulatory burdens and expenses
for which we have not allotted funds. Unless we are able to modify our activities so that we would not be deemed an investment company,
we would either register as an investment company or wind down and abandon our efforts to complete the Proposed Business Combination or
another Initial Business Combination and instead liquidate the Company. As a result, our Public Shareholders may only receive their pro
rata portion of the funds in the Trust Account that are available for distribution to Public Shareholders and would be unable to realize
the potential benefits of the Proposed Business Combination or another Initial Business Combination, including the possible appreciation
of the combined company’s securities, and our Warrants would expire worthless. For illustrative purposes, in connection with the
liquidation of our Trust Account, our Public Shareholders may receive only approximately $11.95$12.07 per Public Share, which is based on estimates
as of OctoberMarch 31,30, 2025,2026, or less in certain circumstances, and our Warrants would expire worthless.
The net proceeds from the
Initial Public Offering and the sale of the Private Placement Warrants provided us with approximately $333 million to complete our Initial
Business Combination and pay related fees and expenses. Following the redemptions in connection with the Extensions, as of OctoberMarch 31,30, 2026,
2025, we had a remaining balance in cash held in trust of approximately $1.86$1.3 million.
Our Charter does not currently
provide a specified maximum redemption threshold. Although the Proposed Business Combination does not, another Initial Business Combination
may impose a minimum cash requirement for: (i) cash consideration to be paid to the target or its owners, (ii) cash for working capital
or other general corporate purposes or (iii) the retention of cash to satisfy other conditions. We may be able to complete an Initial
Business Combination even though a substantial majority of the Public Shares issued in our Initial Public Offering have already been redeemed
in connection with the Extensions. Similarly, if we seek shareholder approval of an Initial Business Combination, as we intend to do in
connection with the Proposed Business Combination, and do not conduct redemptions pursuant to the tender offer rules, we may enter into
privately negotiated agreements with Public Shareholders to sell their shares to our Sponsor, officers, directors, advisors or any of
their affiliates. In the event the aggregate cash consideration we would be required to pay for all Public Shares that are validly submitted
for redemption plus any amount required to satisfy cash requirements pursuant to the terms of our Initial Business Combination exceed
the aggregate amount of cash available to us, and if the minimum cash condition is not waived, we will not complete an Initial Business
Combination or redeem any Public Shares, all Public Shares submitted for redemption will be returned to the holders thereof, and we instead
may search for an alternate Initial Business Combination. This risk is magnified because, following redemptions in connection with the
Extensions, as of OctoberMarch 31,30, 2025,2026, we had a balance in cash held in trust of approximately $1.86$1.3 million.
Although we believe that the
remaining net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, plus the proceeds of loans from
our Sponsor, its affiliates or members will be sufficient to allow us to complete the Proposed Business Combination or another Initial
Business Combination, we cannot ascertain the capital requirements for any particular transaction. Because of the redemptions in connection
with Public Shares, the depletion of the available net proceeds in search of a target business, the size of the Proposed Business Combination
or another Initial Business Combination, or the terms of negotiated transactions to purchase shares in connection with the Proposed Business
Combination or another Initial Business Combination, we will be required to seek additional financing or to abandon the Proposed Business
Combination or another Initial Business Combination. We cannot assure investors that such financing will be available on acceptable terms,
if at all. The current economic environment may make it difficult for companies to obtain acquisition financing. To the extent that additional
financing proves to be unavailable for the Proposed Business Combination or such other Initial Business Combination, we would be compelled
to either restructure the transaction or abandon the Proposed Business Combination or other Initial Business Combination and seek an alternative
target business candidate. This risk is magnified because, following redemptions in connection with the Extensions, as of OctoberMarch 31,30, 2026,
2025, we had a balance in cash held in trust of approximately $1.86$1.3 million. If we have not consummated the Proposed Business Combination or
or another Initial Business Combination within the required time period, our Public Shareholders may receive only approximately $10.00 per
per Public Share, or less in certain circumstances, on the liquidation of our Trust Account and our Warrants will expire worthless. In addition,
addition, even if we do not need additional financing to complete the Proposed Business Combination or another Initial Business Combination, we
we will likely require such financing to fund the operations or growth of iRocket or another target business. The failure to secure additional
financing could have a material adverse effect on the continued development or growth of iRocket or such other target business.
Our
Sponsor owns, on an as-converted
basis, 98.23%98.7% of the voting power of our issued and outstanding ordinary shares. Accordingly, it controls actions requiring
a shareholder vote,
potentially in a manner that Public Shareholders may not support, including amendments to our Charter. If our Sponsor
purchases any additional
Class A Ordinary Shares in the aftermarket or in privately negotiated transactions, this would increase its
control. Neither our Sponsor
nor, to our knowledge, any of our officers or directors, have any current intention to purchase additional
securities, other than as disclosed
in this Annual Report. Factors that would be considered in making such additional purchases would
include consideration of the current
trading price of our Class A Ordinary Shares. In addition, our board of directors, whose members
were initially elected by our Sponsor,
is divided into three classes, each of which will generally serve for a term of three years with
only one class of directors being elected
in each year. We may not hold an annual meeting of shareholders to elect new directors prior
to the completion of the Proposed Business
Combination or another Initial Business Combination, in which case all of the current directors
will continue in office until at least
the completion of the Proposed Business Combination or another Initial Business Combination. If
there is an annual meeting, as a consequence
of our “staggered” board of directors, only a minority of the board of directors
will be considered for election and our Sponsor,
because of its ownership position, will control the outcome, as only holders of our
Class B ordinary shares will have the right to vote
on the election of directors and to remove directors prior to the Proposed Business
Combination or another Initial Business Combination.
Accordingly, our Sponsor will continue to exert control at least until the completion
of the Proposed Business Combination or another
Initial Business Combination. In addition, we have agreed not to enter into a definitive
agreement regarding an Initial Business Combination
without the prior consent of our Sponsor. Our Sponsor consented to our entry into
the Merger Agreement with iRocket.
If
we have not consummated the Proposed
Business Combination or another Initial Business Combination by MarchSeptember 16, 2026, our Public Shareholders
may be forced to wait beyond March
September 16, 2026 before redemption from our Trust Account.
If
we have not consummated
the Proposed Business Combination or another Initial Business Combination by MarchSeptember 16, 2026, the proceeds then
on deposit in the Trust
Account, including interest earned on the funds held in the Trust Account and not previously released to us to
pay our income taxes, if
any (less taxes payable and up to $100,000 of interest to pay dissolution expenses), will be used to fund the
redemption of our Public
Shares, as further described herein. Any redemption of Public Shareholders from the Trust Account will be effected
automatically by function
of our Charter prior to any voluntary winding up. If we are required to wind up, liquidate the Trust Account
and distribute such amount
therein, pro rata, to our Public Shareholders, as part of any liquidation process, such winding up, liquidation
and distribution must
comply with the applicable provisions of the Companies Act. In that case, investors may be forced to wait beyond
March September 16, 2026, before
the redemption proceeds of our Trust Account become available to them, and they receive the return of their pro
rata portion of the proceeds
from our Trust Account. We have no obligation to return funds to investors prior to the date of our redemption
or liquidation unless,
prior thereto, we consummate the Proposed Business Combination or another Initial Business Combination or amend
certain provisions of
our Charter, and only then in cases where investors have sought to redeem their Public Shares. Only upon our redemption
or any liquidation
will Public Shareholders be entitled to distributions if we do not complete the Proposed Business Combination or another
Initial Business
Combination and do not amend certain provisions of our Charter. Our Charter will provide that, if we wind up for any
other reason prior
to the consummation of the Proposed Business Combination or another Initial Business Combination, we will follow the
foregoing procedures
with respect to the liquidation of the Trust Account as promptly as reasonably possible but not more than ten business
days thereafter,
subject to applicable Cayman Islands law.
Our
remaining Public Shareholders
will be entitled to receive funds from the Trust Account only upon the earliest to occur of: (i) our completion
of the Proposed Business
Combination or another Initial Business Combination, and then only in connection with those Public Shares that
such Public Shareholder
properly elected to redeem, subject to the limitations described herein, (ii) the redemption of any Public Shares
properly tendered in
connection with a shareholder vote to amend our Charter (A) to modify the substance or timing of our obligation
to provide Public Shareholders
the right to have their Public Shares redeemed in connection with the Proposed Business Combination or
another Initial Business Combination
or to redeem 100% of our Public Shares if we do not complete the Proposed Business Combination or
another Initial Business Combination
by MarchSeptember 16, 2026 or (B) with respect to any other provision relating to the rights of Public Shareholders
or pre-Initial Business
Combination activity, and (iii) the redemption of our Public Shares if we have not consummated the Proposed Business
Combination or another
Initial Business Combination by MarchSeptember 16, 2026, subject to applicable law and as further described herein. Public
Shareholders who
redeem their Public Shares in connection with a shareholder vote described in clause (ii) in the preceding sentence
shall not be entitled
to funds from the Trust Account upon the subsequent completion of the Proposed Business Combination or another
Initial Business Combination
or liquidation if we have not consummated an Initial Business Combination by MarchSeptember 16, 2026, with respect
to such Public Shares so
redeemed. In no other circumstances will a Public Shareholder have any right or interest of any kind in the
Trust Account. Holders of
Warrants will not have any right to the proceeds held in the Trust Account with respect to the Warrants. Accordingly,
to liquidate their
investment, Public Shareholders may be forced to sell their Public Shares or Warrants, potentially at a loss.
The nominal purchase price paid by our Sponsor for the Founder Shares and Preference Shares may result in significant dilution to the implied value of your Public Shares upon the consummation of the Proposed Business Combination or another Initial Business Combination.
We offered our Units at an
offering price of $10.00 per Unit and, as of OctoberMarch 31,30, 2025,2026, the amount in our Trust Account was approximately $1.86$1.3 million, implying
a value of approximately $11.95$12.07 per Public Share. However, prior to our Public Offering, our Sponsor paid a nominal aggregate purchase
price of $25,000 for the Founder Shares, or approximately $0.003 per share, and on March 15, 2024, pursuant to the Class A Conversion,
our Sponsor converted 4,300,000 Class B ordinary shares into an equal number of Class A Conversion Shares. Our Sponsor agreed to waive
its redemption rights with respect to such Class A Conversion Shares in connection with a shareholder vote to approve an Initial Business
Combination (including the Proposed Business Combination) and its right to receive any distribution from the Trust Account with respect
to such Class A Conversion Shares. On February 13, 2026, the Sponsor surrendered to the Company, for no consideration, the 4,300,000 Class
A Conversion Shares. Also on February 13, 2026, the Sponsor purchased 430,000 Preference Shares. Our Sponsor agreed to waive any redemption
rights with respect to such Preference Shares in connection with a shareholder vote to approve an Initial Business Combination (including
the Proposed Business Combination) and any right to receive any distribution from the Trust Account with respect to such Preference Shares.
Each Preference Share will convert into ten Class A Ordinary Shares immediately prior to, concurrently with, or immediately filing closing
of an Initial Business Combination, including the Proposed Business Combination. As a result, the value of our Public Shareholders’
Public Shares may be significantly diluted
upon the consummation of the Proposed Business Combination or another Initial Business Combination,
when the remaining Founder Shares
and Preference Shares are converted into Class A Ordinary Shares. For example, the following table shows
the dilutive effect of the Founder Shares and the Class
A ConversionPreference Shares on the implied value of the Public Shares that remain outstanding
following the Fourth Extension upon the consummation
of the Proposed Business Combination or another Initial Business Combination assuming
that our equity value at that time is $1,860,032,
$1,332,638, which is the approximate amount we would have for the Proposed Business Combination
or another Initial Business Combination in the Trust Account assuming
no further interest is earned on the funds held in the Trust Account,
no additional extension payments are made into the Trust Account
and none of the remaining Public Shares are redeemed in connection with
the Proposed Business Combination or such other Initial Business
Combination, and without taking into account any other potential impacts
on our valuation at such time, such as the trading price of our
Public Shares, the business combination transaction costs, any equity
issued or cash paid to the target’s sellers or other third
parties, or the target’s business itself, including its assets,
liabilities, management and prospects, as well as the value of our
Public Warrants and Private Placement Warrants. At such valuation,
each of our ordinary shares would have an implied value of approximately
$0.21 $0.15 per share upon consummation of the Proposed Business Combination
or another Initial Business Combination, which is a 97.9%98.5% decrease
as compared to the initial implied value per Public Share of $10.00.
Our
Sponsor invested in us
an aggregate of approximately $8,925,000, comprised of the $25,000 purchase price for the Founder Shares and the
$8,900,000 purchase price
for the Private Placement Warrants. On March 15, 2024, pursuant to the Class A Conversion, our Sponsor converted
4,300,000 Founder Shares
into Class A Conversion Shares. On February 13, 2026, pursuant to the Class A Conversion Share Forfeiture, the Sponsor surrendered for
no consideration the Class A Conversion Shares. Also on February 13, 2026, the Sponsor purchased 430,000 Preference Shares. Each Preference
Share will convert into ten Class A Ordinary Shares immediately prior to, concurrently with, or immediately filing closing of an Initial
Business Combination, including the Proposed Business Combination. Assuming a trading price of $10.00 per share upon consummation of an
Initial Initial
Business Combination, the 8,625,000 aggregate number of Founder Shares and Class A ConversionOrdinary Shares issuable to the Sponsor at closing would have
an aggregate implied
value of $86,250,000. Even if the trading price of our ordinary shares were as low as $1.03 per share, and the Private
Placement Warrants
were worthless, the aggregate value of thesuch Founder Shares and Class A Conversion Sharesshares would be equal to the Sponsor’s initial
investment in us.
Our
Charter authorizes the
issuance of up to 500,000,000 Class A Ordinary Shares, par value $0.0001 per share, 50,000,000 Class B ordinary
shares, par value $0.0001
per share, and 1,000,000 preference shares, par value $0.0001 per share. There are 495,544,386499,889,581, 45,675,000, and 45,675,000
570,000 authorized but
unissued Class A Ordinary Shares andShares, Class B ordinary shares and preference shares, respectively, available for issuance which amount does
not not
take into account shares reserved for issuance upon exercise of outstanding Warrants or shares issuable upon conversion of the Founder
Shares, if any. The Founder Shares and the Preference Shares will automatically convert into Class A Ordinary Shares (which Class A Ordinary
Shares delivered upon
conversion will not have any redemption rights or be entitled to liquidating distributions from the Trust Account
if we fail to consummate
the Proposed Business Combination or another Initial Business Combination) at the time of the Proposed Business
Combination or such other
Initial Business Combination or earlier at the option of the holders thereof as described herein and in our Charter.
As
a result, included on our
balance sheet as of June 30, 2025, and December 31, 2024, 20232025 and 20222024, are derivative liabilities related
to embedded features contained within our Warrants.
Financial Accounting Standard Board’s Accounting Standards Update (“ASU”)
815, Derivatives and Hedging, provides
for the remeasurement of the fair value of such derivatives at each balance sheet date, with a
resulting non-cash gain or loss related
to the change in the fair value being recognized in earnings in the statement of operations.
As a result of the recurring fair value measurement,
our financial statements and results of operations may fluctuate, based on factors,
which are outside of our control. Due to the recurring
fair value measurement, we expect that we will recognize non-cash gains or losses
on our Warrants each reporting period and that the amount
of such gains or losses could be material. The impact of changes in fair value
on earnings may have an adverse effect on the market price
of our securities.
In connection with the Company’s
assessment of going concern considerations in accordance with ASC 205-40, “Presentation of Financial Statements - Going Concern,”
we have until MarchSeptember 16, 2026 to consummate the Proposed Business Combination or another Initial Business Combination. While we have
entered entered
into the Merger Agreement for the Proposed Business Combination, there can be no assurances that the Proposed Business Combination
will will
be consummated on the terms or timeframe currently contemplated, or at all. In the event the Proposed Business Combination is not
consummated, consummated,
it is uncertain that we will be able to consummate another Initial Business Combination with another company or business
by MarchSeptember 16,
2026. If the Proposed Business Combination or another Initial Business Combination is not consummated by this date, there
will be a mandatory
liquidation and subsequent dissolution of our Company. Management has determined that the mandatory liquidation, should
the Proposed Business
Combination or another Initial Business Combination not occur, and potential subsequent dissolution, raises substantial
doubt about our
ability to continue as a going concern.
On November 14, 2023, to document
the deposits by the Sponsor into the Trust Account in connection with the implementation of the Second Extension Amendment Proposal, the
Company issued the Extension Note in the aggregate principal amount of up to $450,000 to the Sponsor. Pursuant to the Extension Note,
and in connection with the implementation of the Second Extension Amendment Proposal, the Sponsor was permitted, but not obligated to,
deposit $75,000 for each calendar month (commencing on September 16, 2023 and ending on the 15th day of each subsequent month),
or portion thereof, that is needed by the Company to complete an Initial Business Combination until March 16, 2024, resulting in a maximum
contribution of $450,000. As of March 16, 2024, the Sponsor had deposited the maximum contribution of $450,000. As of March 16, 2024,
the Sponsor had deposited the maximum contribution of $450,000. Pursuant to the Member Agreement, the amounts owed to the Sponsor under
the Extension Note were forgiven. Before such amounts were forgiven, we were to repay the Extension Note out of the proceeds of the Trust
Account released to us and other proceeds of the transaction if we completed an Initial Business Combination. In the event that we did
not complete an Initial Business Combination, we were to be permitted to use a portion of the proceeds held outside the Trust Account
to repay the Extension Note but no proceeds held in the Trust Account were to be used to repay the Extension Note. As of June 30, 2025,
and December 31, 2024, 2023,
2025 and 2022,2024, we had borrowings of $0,$450,000 $450,000,under $300,000the Extension Note, which was forgiven as part of the Member Agreement, and $0,a respectivelycontribution
of forcapital extensionof payments.$450,000 was recognized during the year ended December 31, 2024.
The personal and financial
interests of our executive officers and directors may influence their motivation in identifying and selecting a target business, completing
an Initial Business Combination, including the Proposed Business Combination, and influencing the operation of the business following
an Initial Business Combination, including the Proposed Business Combination. This risk may become more acute as MarchSeptember 16, 2026, nears,
which is the deadline for our consummation of the Proposed Business Combination or another Initial Business Combination.
In
order to effectuate a business
combination, blank check companies have, in the recent past, amended various provisions of their charters
and governing instruments, including
their warrant agreements. For example, blank check companies have amended the definition of business
combination, increased redemption
thresholds, extended the time to consummate an initial business combination and, with respect to their
warrants, amended their warrant
agreements to require the warrants to be exchanged for cash and/or other securities. Amending our Charter
will require at least a special
resolution of our shareholders as a matter of Cayman Islands law, meaning the approval of holders of
at least two-thirds of our ordinary
shares who attend and vote at a shareholder meeting of the Company, and amending our warrant agreement
will require a vote of holders
of at least 65% of the Public Warrants and, solely with respect to any amendment to the terms of the Private
Placement Warrants or any
provision of the warrant agreement with respect to the Private Placement Warrants, 65% of the number of the
then outstanding Private Placement
Warrants. In addition, our Charter requires us to provide our Public Shareholders with the opportunity
to redeem their Public Shares for
cash if we propose an amendment to our Charter (A) that would modify the substance or timing of our
obligation to provide Public Shareholders
the right to have their Public Shares redeemed in connection with an Initial Business Combination,
including the Proposed Business Combination,
or to redeem 100% of our Public Shares if we do not complete the Proposed Business Combination
or another Initial Business Combination
by MarchSeptember 16, 2026, or (B) with respect to any other provision relating to the rights of Public
Shareholders or pre-Initial Business
Combination activity. This risk is exacerbated by the fact that our Sponsor owns 98.2% of our outstanding
Ordinary Shares, and therefore
controls the outcome of any shareholder vote. To the extent any of such amendments would be deemed to
fundamentally change the nature
of any of the securities offered in the Initial Public Offering, we would register, or seek an exemption
from registration for, the affected
securities.
Some
other blank check companies
have a provision in their charter which prohibits the amendment of certain of its provisions, including those
which relate to the rights
of a company’s shareholders, without approval by a certain percentage of the company’s shareholders.
In those companies, amendment
of these provisions typically requires approval by between 90% and 100% of the company’s shareholders.
Our Charter provides that
any provisions related to the rights of Public Shareholders (including the requirement to deposit proceeds
of the Initial Public Offering
and the sale of the Private Placement Warrants into the Trust Account and not release such amounts except
in specified circumstances,
and to provide redemption rights to Public Shareholders as described herein) may be amended if approved by
special resolution, meaning
holders of at least two-thirds of our ordinary shares who attend and vote at a shareholder meeting of the
Company, and corresponding provisions
of the trust agreement governing the release of funds from our Trust Account may be amended if
approved by holders of at least 65% of
our ordinary shares; provided that the provisions of our Charter governing the appointment
or removal of directors prior to our
Initial Business Combination may only be amended by a special resolution passed by not less than
two-thirds of our ordinary shares who
attend and vote at our shareholder meeting which shall include the affirmative vote of a simple
majority of our Founder Shares. Our Sponsor
and its permitted transferees, if any, who collectively beneficially own 98.2%98.7% of the voting power of our ordinary
outstanding shares, will participate
in any vote to amend our Charter and/or trust agreement and will have the discretion to vote in any manner they
choose. As a result, with
the support of the Sponsor, we would be able to amend the provisions of our Charter which govern our pre-business
combination behavior
more easily than some other blank check companies, and this may increase our ability to complete an Initial Business
Combination with
which shareholders do not agree. Our shareholders may pursue remedies against us for any breach of our Charter.
Our
Sponsor, executive officers
and directors have agreed, pursuant to agreements with us, that they will not propose any amendment to our
Charter (A) that would modify
the substance or timing of our obligation to provide Public Shareholders the right to have their Public
Shares redeemed in connection
with an Initial Business Combination, including the Proposed Business Combination, or to redeem 100% of
our Public Shares if we do not
complete the Proposed Business Combination or another Initial Business Combination by MarchSeptember 16, 2026 or
(B) with respect to any other
provision relating to the rights of Public Shareholders or pre-Initial Business Combination activity, unless
we provide our Public Shareholders
with the opportunity to redeem their Public Shares upon approval of any such amendment at a per-share
price, payable in cash, equal to
the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held
in the Trust Account and not previously
released to us to pay our income taxes, if any, divided by the number of the then-outstanding
Public Shares. Our shareholders are not
parties to, or third-party beneficiaries of, these agreements and, as a result, will not have
the ability to pursue remedies against our
Sponsor, executive officers or directors for any breach of these agreements. As a result,
in the event of a breach, our shareholders would
need to pursue a shareholder derivative action, subject to applicable law.
Moreover,
the process of government
review, whether by the CFIUS or otherwise, could be lengthy and the Company has limited time to complete the
Proposed Business Combination
or another Initial Business Combination. If the Company cannot complete the Proposed Business Combination
or another Initial Business
Combination by MarchSeptember 16, 2026, or such later date that may be approved by the Company’s shareholders,
because the review process
extends beyond such timeframe or because the Proposed Business Combination or such other Initial Business
Combination is ultimately prohibited
by CFIUS or another U.S. government entity, the Company may be required to liquidate.
Management's Discussion & Analysis (MD&A)
Removed heading “Net Income per Ordinary Share”
Largest changes
“On January 17, 2023, we entered into the Terminated Business Combination Agreement with APRINOIA, PubCo and the Merger Subs. The transactions contemplated by the Terminated Business Combination Agreement are referred to herein as the Terminated Business Combination. The terms of the Terminated Business Combination and the other transactions contemplated thereby are summarized in the Company’s Current Report on Form 8-K filed with the SEC on January 18, 2023. …”see in full comparison
On July 22, 2025, we entered into the Merger Agreement, with Holdco, Holdco Merger Sub, Acquiror Merger Sub, and iRocket. Subject to its terms and conditions, the Merger Agreement provides that (i) on the day prior to the date of the Mergersee in full comparison2,2 (as defined below), wewill complete Merger 1 by mergingmerge with and into Holdco Merger Sub, with Holdco Merger Sub being the surviving entity and a wholly owned subsidiary ofHoldco,Holdco (“Merger 1”), and (ii) on the day after Merger 1, Acquiror Merger Sub willcomplete Merger 2 by mergingmerge with and into iRocket, with iRocket being the survivingentity.entity (“Merger 2,” together with Merger 1, the “Mergers,” and the Mergers, together with the other transactions contemplated by the Merger Agreement, as amended, the “Proposed Business Combination”). As a result of the Mergers, iRocket will become an indirect wholly-owned subsidiary of Holdco.
“Three and Six Months ended June 30, 2025, 2024 and 2023: For the three months ended June 30, 2025, we had net loss of approximately $6.4 million, which consisted of approximately $1.2 million in general and administrative expenses, approximately $5.3 million in non-operating loss resulting from the change in fair value of derivative warrant liabilities, partially offset by approximately $15,000 of income from investments held in the Trust Account. …”see in full comparison
“For the six months ended June 30, 2025, we had net loss of approximately $6.4 million, which consisted of approximately $1.2 million in general and administrative expenses, approximately $5.3 million in non-operating loss resulting from the change in fair value of derivative warrant liabilities, partially offset by approximately $29,000 of income from investments held in the Trust Account. …”see in full comparison
“Three Months ended March 31, 2025, 2024 and 2023: For the three months ended March 31, 2025, we had net loss of approximately $3,000, which consisted of approximately $15,000 in general and administrative expenses, approximately $2,000 in non-operating loss resulting from the change in fair value of derivative warrant liabilities, partially offset by approximately $14,000 of income from investments held in the Trust Account. …”see in full comparison
Full comparison: every changed paragraph (40)
The
following discussion
and analysis of the Company’s financial condition and results of operations should be read in conjunction
with ourits audited consolidated financial
statements and the notes related thereto, including our unaudited condensed consolidated financial
statement for the quarters ended March 31, 2024, June 30, 2024, September 30, 2024, March 31, 2025 and June 30, 2025,thereto which are included in “Item 8. Financial Statements and Supplementary Data” of this
inReport, as well as the sections of this Report.Report entitled “Item 1. Business” and “Item 1A. Risk Factors.” Certain
information contained in the discussion and analysis set forth below includes forward-looking statements. Our
The Company’s actual results
may differ materially from those anticipated in these forward-looking statements as a result of many factors, including
those set forth
under “SpecialCautionary Note Regarding Forward-Looking Statements,” “Item 1A. Risk Factors” and elsewhere
in this Report.Report
on Form 10-K.
On
July 22, 2025, we entered
into the Merger Agreement, with Holdco, Holdco Merger Sub, Acquiror Merger Sub, and iRocket. Subject to its
terms and conditions, the
Merger Agreement provides that (i) on the day prior to the date of the Merger 2,2 (as defined below), we will complete Merger 1
by mergingmerge with and into Holdco Merger
Sub, with Holdco Merger Sub being the surviving entity and a wholly owned subsidiary of Holdco,
Holdco (“Merger 1”), and (ii)
on the day after Merger 1, Acquiror Merger Sub will complete Merger 2 by mergingmerge with and into iRocket, with iRocket being the
surviving entity.entity (“Merger
2,” together with Merger 1, the “Mergers,” and the Mergers, together with the other transactions contemplated
by the Merger Agreement, as amended, the “Proposed Business Combination”). As a result of the Mergers, iRocket will
become an indirect wholly-owned subsidiary of Holdco.
On October 6, 2025, we, Holdco, Holdco Merger Sub, Acquiror Merger Sub, and iRocket entered into Merger Agreement Amendment 1, pursuant to which Section 7.07 of the Merger Agreement was amended to extend the deadline for the Company to file its Multi-Year 10-K from October 6, 2025 to October 31, 2025.
On October 30, 2025, we, Holdco, Holdco Merger Sub, Acquiror Merger Sub, and iRocket entered Merger Agreement Amendment 2, pursuant to which Section 7.07 of the Merger Agreement was amended to extend the deadline for the Company to file its Multi-Year 10-K from October 31, 2025 to November 30, 2025.
On December 12, 2025, we, Holdco, Holdco Merger Sub, Acquiror Merger Sub, and iRocket entered into Merger Agreement Amendment 3, pursuant to which Section 7.06(a) of the Merger Agreement was amended to extend the deadline for the Company’s securities to be qualified for quotation on the OTC Markets Group from ten (10) Business Days following the filing of the Multi-Year 10-K to December 31, 2025, or such later date as mutually agreed in writing by the Company and iRocket.
Terminated
Business Combination with APRINOIA Therapeutics Inc.
On
January 17, 2023, we entered into the Terminated Business Combination Agreement with APRINOIA, PubCo and the Merger Subs. The transactions
contemplated by the Terminated Business Combination Agreement are referred to herein as the Terminated Business Combination. The terms
of the Terminated Business Combination and the other transactions contemplated thereby are summarized in the Company’s Current
Report on Form 8-K filed with the SEC on January 18, 2023. Effective as of August 21, 2023 and in accordance with Section 11.01(a) of
the Terminated Business Combination Agreement, the Company, APRINOIA, PubCo and the Merger Subs mutually agreed to terminate the Terminated
Business Combination Agreement and, consequently, the other Transaction Documents (as defined in the Terminated Business Combination
Agreement) pursuant to the terms of the Termination Agreement. Further, under the Termination Agreement, each of the Company, Merger
Sub 2 and Merger Sub 3 released APRINOIA, PubCo and Merger Sub 1, and each of their representatives, affiliates, agents and assigns,
and each of APRINOIA, PubCo and Merger Sub 1 released the Company, Merger Sub 2 and Merger Sub 3, and each of their representatives,
affiliates, agents and assigns, for any claims, causes of action, liabilities or damages relating to the Terminated Business Combination
Agreement and the other Transaction Documents, except for certain provisions that survive the termination pursuant to the terms of the
Terminated Business Combination Agreement, or for breaches of the Termination Agreement. Further details regarding the termination and
the Termination Agreement may be found in the Company’s Current Report on Form 8-K filed with the SEC on August 21, 2023.
On March 16, 2026, the Company held the Fifth Extension Meeting. At the Fifth Extension Meeting, the Company’s shareholders approved the Fifth Extension Amendment Proposal. In connection with the vote to approve the Fifth Extension Amendment Proposal, the holders of 45,195 Public Shares of the Company properly exercised their right to redeem their shares for cash at a redemption price of approximately $12.07 per share, for an aggregate redemption amount of approximately $545 thousand.
Following the aforementioned
redemptions, extensionsExtensions, andthe 2024 Conversion, the Class A Conversion,Conversion Share Forfeiture and the Preference Share Issuance, as of OctoberMarch 31, 2025,30,
2026, our outstanding share capital consists of 4,455,614110,419 Class
A Ordinary Shares, all of which 155,614 are Public Shares, and 4,325,000 Class B ordinaryOrdinary
Shares shares.and 430,000 Preference Shares.
On November 14, 2023, to document
the deposits by the Sponsor into the Trust Account in connection with the implementation of the Second Extension Amendment Proposal, we
issued the Extension Note in the aggregate principal amount of up to $450,000 to the Sponsor. Pursuant to the Extension Note, and in connection
with the implementation of the Second Extension Amendment Proposal, the Sponsor was permitted, but not obligated to, deposit $75,000 for
each calendar month (commencing on September 16, 2023 and ending on the 15th day of each subsequent month), or portion thereof,
that is needed by us to complete an Initial Business Combination until March 16, 2024, resulting in a maximum extension payment of $450,000.
As of March 16, 2024, the Sponsor had deposited the maximum contribution of $450,000. Pursuant to the Member Agreement, the amounts owed
to the Sponsor under the Extension Note were forgiven. Before such amounts were forgiven, we were to repay the Extension Note out of the
proceeds of the Trust Account released to us and other proceeds of the transaction if we completed an Initial Business Combination. In
the event that we did not complete an Initial Business Combination, we were to be permitted to use a portion of the proceeds held outside
the Trust Account to repay the Extension Note but no proceeds held in the Trust Account were to be used to repay the Extension Note. .
As
of June 30, 2025, and December 31, 2024, 2023,2025 and 2022,2024, we had borrowings of $0, $450,000, $300,000 and $0, respectively$450,000 for extension payments, of which has since been forgiven and recorded
payments.as capital contribution.
If
we are unable to complete
the Proposed Business Combination or an Initial Business Combination by MarchSeptember 16, 2026 or such later date by
which we must complete
the Proposed Business Combination or another Initial Business Combination pursuant to an amendment to our Charter,
we will (i) cease all
operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten
business days thereafter,
redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit
in the Trust Account, including
interest earned on the funds held in the Trust Account and not previously released to us to pay our tax
obligations, if any (less taxes
payable and up to $100,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding
Public Shares, which
redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to
receive further liquidation
distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to
the approval of the remaining
shareholders and the board of directors, liquidate and dissolve, subject in the case of clauses (ii) and
(iii), to our obligations under
Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.
As of June 30, 2025, December
31, 2024, and December 31, 2023,2025, we
had approximately $0, $0, and $10,420$0 in our operating bank account and working capital deficit of
approximately $2.9$4.5 million, $1.7 million, and $8.1 million, respectively.million.
Our
liquidity needs through
December June 30,31, 2025 and prior were satisfied through a payment of $25,000 from the Sponsor to purchase certain expenses
in exchange for
the issuance of the Founder Shares, the loan of approximately $90,000 from the Sponsor under the IPO Promissory Note
and the proceeds
from the consummation of the Private Placement not held in the Trust Account. We repaid the IPO Promissory Note in full
on March 19, 2021.
On November 14, 2023, to document
the deposits by the Sponsor into the Trust Account in connection with the implementation of the Second Extension Amendment Proposal, the
Company issued the Extension Note in the aggregate principal amount of up to $450,000 to the Sponsor. As of March 16, 2024, the Sponsor
had deposited the maximum contribution of $450,000. Pursuant to the Member Agreement, the amounts owed to the Sponsor under the Extension
Note were forgiven. Before such amounts were forgiven, we were to repay the Extension Note out of the proceeds of the Trust Account released
to us and other proceeds of the transaction if we completed an Initial Business Combination. In the event that we did not complete an
Initial Business Combination, we were to be permitted to use a portion of the proceeds held outside the Trust Account to repay the Extension
Note but no proceeds held in the Trust Account were to be used to repay the Extension Note. As of June 30, 2025, and December 31, 2024,
2023,2025 and 2022,2024, we had borrowings
of $0, $450,000, $300,000 and $0, respectively$450,000 for extension payments.payments, of which has since been forgiven and recorded as capital contribution.
On November 14, 2023, to document
existing and future Working Capital Loans, the Company issued the Convertible Note, an unsecured, convertible promissory note, to the
Sponsor, pursuant to which the Company can borrow up to $1,500,000 from the Sponsor, for ongoing expenses reasonably related to the business
of the Company and the consummation of an Initial Business Combination. All unpaid principal under the Convertible Note will be due and
payable in full on the Maturity Date, which is the earlier of (i) MarchSeptember 16, 2026, or such later date by which the Company must consummate
an Initial Business Combination pursuant to its Charter (as may be amended by shareholder vote) and (ii) the effective date of an Initial
Business Combination. The Sponsor has the option, at any time on or prior to the Maturity Date, to convert any amounts outstanding under
the Convertible Note, up to an aggregate amount of $1,500,000, into Warrants to purchase Class A Ordinary Shares of the Company, at a
conversion price of $1.50 per Warrant, with each Warrant entitling the holder to purchase one Class A Ordinary Share at a price of $11.50
per share, subject to the same adjustments applicable to the Private Placement Warrants sold concurrently with the Company’s Initial
Public Offering. As of June 30, 2025, and December 31, 2024, 20232025 and 2022,2024, the Company had borrowed $0, $0, $300,000, and $0, respectively,
from the Sponsor under the Convertible Note. If the Company
completes the Proposed Business Combination or another Initial Business Combination,
the Company will repay the Convertible Note out of
the proceeds of the Trust Account released to the Company (unless the Sponsor elects
to convert the outstanding balance into Warrants
or other arrangements are made). In the event that the Proposed Business Combination
or another Initial Business Combination does not
close, the Company may use a portion of the proceeds held outside the Trust Account to
repay the Convertible Note but no proceeds held
in the Trust Account would be used to repay the Convertible Note.
In connection with the Company’s
assessment of going concern considerations in accordance with ASC 205-40, “Presentation of Financial Statements - Going Concern,”
we have until MarchSeptember 16, 2026 to consummate the Proposed Business Combination or another Initial Business Combination. On September
15, 15,
2023, the Company’s shareholders voted to extend the date by which the Company has to consummate an Initial Business Combination
from September 16, 2023 to March 16, 2024 or such later date by which the Company must complete an Initial Business Combination pursuant
to an amendment to the Company’s Charter. On March 6, 2023, the Company’s shareholders voted to extend the date by which the
Company has to consummate an Initial Business Combination from March 16, 2024 to September 16, 2024 or such later date by which the Company
must complete an Initial Business Combination pursuant to an amendment to the Company’s Charter. On September 16, 2024, the Company’s
shareholders voted to extend the date by which the Company has to consummate an Initial Business Combination from September 16, 2024 to
March 16, 2026 or such later date by which the Company must complete an Initial Business Combination pursuant to an amendment to the Company’s
Charter. On March 16, 2026, the Company’s shareholders voted to extend the date by which the Company has to consummate an Initial
Business Combination from March 16, 2026 to September 16, 2026 or such later date by which the Company must complete an Initial Business
Combination pursuant to an amendment to the Company’s Charter. It is uncertain that we will be able to consummate the Proposed Business
Combination or another Initial Business Combination
by MarchSeptember 16, 2026. Additionally, we may not have sufficient liquidity to fund
our working capital needs until one year from the issuance
of these consolidated financial statements. If the Proposed Business Combination
or another Initial Business Combination is not consummated
by this date, there will be a mandatory liquidation and subsequent dissolution
of the Company. Management has determined that the liquidity
condition and mandatory liquidation, should the Proposed Business Combination
or another Initial Business Combination not occur, and potential
subsequent dissolution, raises substantial doubt about the Company’s
ability to continue as a going concern. No adjustments have
been made to the carrying amounts of assets or liabilities should the Company
be required to liquidate after MarchSeptember 16, 2026.
Our
entire activity from inception
to JuneDecember 30,31, 2025 was in preparation for our formation and the Initial Public Offering, and, subsequent
to the Initial Public Offering,
identifying a target company for an Initial Business Combination, including the Proposed Business Combination.
We will not be generating
any operating revenues until the closing and completion of the Proposed Business Combination or another Initial
Business Combination,
at the earliest.
Year Ended December 31,
2024: For the year ended December
31, 2024,2025, we had net incomeloss of approximately $4.2$16 million, which consisted of approximately $.7
$2.8 million in general and administrative expenses,
approximately $0.8$13.2 million in non-operating loss resulting from the change in fair value
of derivative warrant liabilities, partially
offset by approximately $3.6$0.5 million ofgain forgivenessfrom extinguishment of debt,deferred approximatelyunderwriting $1.2commissions millionand $56,000 of
income from investments
held in the Trust Account, and approximately $0.9 million of gain on extinguishment of extension loans.Account.
Year
Ended December 31, 2023: For the year ended December 31, 2023, we had net income of approximately $4.5 million, which consisted of
$1 million gain from extinguishment of notes payable, approximately $5.6 million of income from investments held in the Trust Account,
and approximately $0.5 million of gain on waived deferred underwriter commission partially offset by approximately $0.2 million in non-operating
gain resulting from the change in fair value of derivative warrant liabilities and approximately $2.4 million in general and administrative
expenses.
Year
Ended December 31, 2022: For the year ended December
31, 2022,2024, we had net income of approximately $14.9$4.2 million, which consisted
of approximately $15.0$.7 million in general and administrative
expenses, approximately $0.8 million in non-operating gainloss resulting from the change in fair value of derivative warrant liabilitiesliabilities,
partially andoffset by approximately
$5.3 $3.6 million of forgiveness of debt, approximately $1.2 million of income from investments held in the
Trust Account, partially offset byand approximately $5.4$0.9 million inof generalgain andon administrative
expenses.extinguishment of extension loans.
Three
and Six Months ended June 30, 2025, 2024 and 2023: For the three months ended June 30, 2025, we had net loss of approximately $6.4
million, which consisted of approximately $1.2 million in general and administrative expenses, approximately $5.3 million in non-operating
loss resulting from the change in fair value of derivative warrant liabilities, partially offset by approximately $15,000 of income from
investments held in the Trust Account. For the three months ended June 30, 2024, we had net income of approximately $68,000, which consisted
of approximately $0.3 million of income from investments held in Trust Account, partially offset by approximately $0.2 million in non-operating
loss resulting from the change in fair value of derivative warrant liabilities and approximately $87,000 in general and administrative
expenses. For the three months ended June 30, 2023, we had net income of approximately $2.3 million, which consisted of approximately
$1.6 million in non-operating gain resulting from the change in fair value of derivative warrant liabilities and approximately $818,000
of income from investments held in Trust Account, partially offset by approximately $77,000 in general and administrative expenses.
For
the six months ended June 30, 2025, we had net loss of approximately $6.4 million, which consisted of approximately $1.2 million in general
and administrative expenses, approximately $5.3 million in non-operating loss resulting from the change in fair value of derivative warrant
liabilities, partially offset by approximately $29,000 of income from investments held in the Trust Account. For the six months ended
June 30, 2024, we had net loss of approximately $1.0 million, which consisted of approximately $1.2 million in general and administrative
expenses, approximately $0.7 million in non-operating loss resulting from the change in fair value of derivative warrant liabilities,
partially offset by approximately $0.9 million of income from investments held in the Trust Account. For the six months ended June 30,
2023, we had net income of approximately $1.4 million, which consisted of approximately $4.4 million of income from investments held
in trust account, partially offset by approximately $1.4 million in general and administrative expenses and approximately $2.1 million
non-operating loss resulting from the change in fair value of derivative warrant liabilities and $457,000 of gain on waived underwriter
commissions.
Three
Months ended March 31, 2025, 2024 and 2023: For the three months ended March 31, 2025, we had net loss of approximately $3,000, which
consisted of approximately $15,000 in general and administrative expenses, approximately $2,000 in non-operating loss resulting from
the change in fair value of derivative warrant liabilities, partially offset by approximately $14,000 of income from investments held
in the Trust Account. For the three months ended March 31, 2024, we had net loss of approximately $1.1 million, which consisted of approximately
$1.1 million in general and administrative expenses, approximately $0.5 million in non-operating loss resulting from the change in fair
value of derivative warrant liabilities, partially offset by approximately $0.6 million income from investments held in the Trust Account.
For the three months ended March 31, 2023, we had net loss of approximately $1.4 million, which consisted of approximately $3.7 million
in non-operating loss resulting from the change in fair value of derivative warrant liabilities and approximately $1.3 million in general
and administrative expenses, partially offset by approximately $3.6 million of income from investments held in Trust Account.
Three
and Nine Months Ended September 30, 2024 and 2023: For the three months ended September 30, 2024, we had net income of approximately
$0.5 million, which consisted of approximately $0.3 million of income from investments held in the Trust Account, and approximately $0.9
million of gain on extinguishment of liabilities, partially offset by approximately $0.7 million in general and administrative expenses,
approximately $42,000 in non-operating loss resulting from the change in fair value of derivative warrant liabilities. For the three
months ended September 30, 2023, we had net income of approximately $2.1 million, which consisted of approximately $1 million in non-operating
gain resulting from the change in fair value of derivative warrant liabilities, $1 million gain from extinguishment of notes payable
and approximately $663,000 of income from investments held in Trust Account, partially offset by approximately $635,000 in general and
administrative expenses.
For
the nine months ended September 30, 2024, we had a net loss of approximately $0.6 million, which consisted of and approximately $1.9
million in general and administrative expenses, approximately $0.7 million in non-operating loss resulting from the change in fair value
of derivative warrant liabilities, partially offset by approximately $1.2 million of income from investments held in the Trust Account,
and approximately $0.9 million of gain on extinguishment of liabilities. For the nine months ended September 30, 2023, we had net income
of approximately $3.5 million, which consisted of approximately $5 million of income from investments held in trust account, $1.0 million
gain from extinguishment of notes payable, and approximately $458,000 of gain on waived underwriter commissions, partially offset by
approximately $2.0 million in general and administrative expenses and approximately $1.0 million non-operating loss resulting from the
change in fair value of derivative warrant liabilities.
Commencing
on the date that
the Company’s securities were first listed on the NYSE, wethe Company agreed to pay ourthe Sponsor a total of $10,000 per month
for office
space, secretarial and administrative services. Upon completion of the Initial Business Combination or the Company’s liquidation,
liquidation,the weCompany will cease paying these monthly fees. As a result of the Member Agreement, the Company terminated the administrative
support agreement and $300,000 was forgiven at year ended December 31, 2024, and was recorded as a capital contribution on the condensed
consolidated statements of shareholders’ deficit.
The
holders of the Founder
Shares, Preference Shares, Private Placement Warrants and Warrants that may be issued upon conversion of the Working Capital Loans, if
if any, are entitled to registration rights pursuant to a registration and shareholder rights agreement signed upon consummation of the Initial
Initial Public Offering. These holders are entitled to certain demand and “piggyback” registration rights. However, the registration
and shareholder rights agreement provides that we would not permit any registration statement filed under the Securities Act to become
effective until the termination of the applicable lock-up period for the securities to be registered. We will bear the expenses incurred
in connection with the filing of any such registration statements.
On
January 19, 2023, the Company
received a waiver of underwriter fees from one of the underwriters in which the underwriter waived its
entitlement to the payment of any
deferred underwriting commission to be paid under the terms of the underwriting agreement. AsThis such,portion accounted for approximately $6.0
$6,037,500,million has been forgiven on which $5,579,875 is presented inof the consolidatedtotal statementdeferred underwriting commission liability of changes$12.1 in shareholders deficit and $457,625
is recognized as a gain on the waiver.million.
By letter agreement dated October 10, 2025, the second underwriter waived its entitlement to the payment of any deferred underwriting commission to be paid under the terms of the underwriting agreement. As such, $6,037,500 has been forgiven, of which $5,579,875 is presented in the accompanying consolidated statements of changes in shareholders’ deficit as additional paid in capital and $457,625 is recognized as a gain on waived deferred underwriter commission on the accompanying consolidated statements of operations.
No deferred underwriting commission is payable.
The Public Warrants and the
Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the
Warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period
until they are exercised. The initial fair value of the Public Warrants issued in connection with the Initial Public Offering were estimated
using a Lattice model and the Private Placement Warrants were estimated using a Lattice model. The fair value of the Public Warrants as
of December 31, 2023 and 2022 is based on observable listed prices for such Public Warrants. As the transfer of Private Placement Warrants
to anyone who is not a permitted transferee would result in the Private Placement Warrants having substantially the same terms as the
Public Warrants, the Company determined that the fair value of each Private Placement Warrant is equivalent to that of each Public Warrant
as of December 31, 20232025 and 2022.2024. The fair value of the Public Warrants as of JuneDecember 30,31, 2025 and December 31, 2024 using the Lattice model. The
The determination of the fair value of the Warrant liability may be subject to change as more current information becomes available and accordingly
accordingly the actual results could differ significantly. Derivative Warrant liabilities are classified as non-current liabilities as
their liquidation
is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Net
Income per Ordinary Share
The Company complies with
accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares,
which are referred to as Class A Ordinary Shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes
of shares. This presentation assumes an Initial Business Combination as the most likely outcome. Net income per ordinary share is calculated
by dividing the net income by the weighted average shares of ordinary shares outstanding for the respective period.
The
calculation of diluted net income (loss) does not consider the effect of the Warrants underlying the Units sold in the Initial Public
Offering (including the consummation of the over-allotment) and the Private Placement Warrants to purchase an aggregate of 17,433,333
Class A Ordinary Shares in the calculation of diluted income (loss) per share, because in the calculation of diluted income (loss) per
share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method.
As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the years ended December 31, 2024,
2023 and 2022 and the six months ended June 30, 2025. The initial accretion associated with the redeemable Class A Ordinary Shares was
excluded from earnings per share as the redemption value approximated fair value. Changes in redemption value in the subsequent periods
is recognized as a deemed dividend to shareholders in the calculation of net income per ordinary share.
In November 2024, the FASB issued ASU 2024-03, “Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses”, requiring public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03.
In
December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires disaggregated
information about a reporting entity’s effective tax rate reconciliation, as well as information related to income taxes paid to
enhance the transparency and decision usefulness of income tax disclosures. This ASU will be effective for the annual period ending December 31,
2025. The Company is currently evaluating the impacts of adoption of this ASU.
In
November 2023, the FASB issued ASU 2023-07 - Segment Reporting (Topic ASC 280) Improvements to Reportable Segment Disclosures
(“ASU 2023-07”). ASU 2023-07 improves reportable segment disclosure requirements, primarily through enhanced disclosure
about significant segment expenses. The enhancements under this update require disclosure of significant segment expenses that are regularly
provided to the Chief Operating Decision Maker (“CODM”) and included within each reported measure of segment profit
or loss, require disclosure of other segment items by reportable segment and a description of the composition of other segment items,
require annual disclosures under ASC 280 to be provided in interim periods, clarify use of more than one measure of segment profit or
loss by the CODM, require that the title of the CODM be disclosed with an explanation of how the CODM uses the reported measures of segment
profit or loss to make decisions, and require that entities with a single reportable segment provide all disclosures required by this
update and required under ASC 280. The Company adopted ASU 2023-07 for the annual period ending December 31, 2024.
In June 2022, the FASB issued
ASU 2022-03, ASC Subtopic 820 Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions(“ASU
2022-03”). ASU 2022-03 amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity
security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that
are measured at fair value. ASU 2022-03 applies to both holders and issuers of equity and equity-linked securities measured at fair value.
The amendments in ASU 2022-03 are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods within
those fiscal years. Early adoption is permitted for both interim and annual consolidated financial statements that have not yet been issued
or made available for issuance. The Company adopted ASU 2022-03 on December 31, 2023. The adoption of ASU 2022-03 did not have a material
impact on its consolidated financial statements.
In
June 2016, the FASB issued ASU 2016-13 – Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses
on Financial Instruments (“ASU 2016-13”). This update requires financial assets measured at amortized cost basis
to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on relevant information
about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability
of the reported amount. Since June 2016, the FASB issued clarifying updates to the new standard including changing the effective date
for smaller reporting companies. The guidance is effective for fiscal years beginning after December 15, 2022, and interim periods within
those fiscal years, with early adoption permitted. The Company adopted ASU 2016-13 on January 1, 2023. The adoption of ASU 2016-13 did
not have a material impact on its consolidated financial statements.
As
of June 30, 2025, 2024 and 2023, March 31, 2025, 2024 and 2023, December 31, 2025 and
2024, 2023we and 2022, and September 30, 2024 and 2023, we
did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.
What changed in the latest 10-Q
Risk Factors
As of the date of this Quarterly Report on Form 10-Q, other than the risk factors included below, there have been no material changes to the risk factors disclosed in our Form 10-K filed with the SEC on November 28, 2025, as amended in January 2026. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
Removed heading “Delisting from NYSE”
Largest changes
“On March 18, 2024, the Company received notice from the NYSE informing us that it would suspend the listing of the Company’s securities, including the Class A Ordinary Shares, Warrants and Units, from the NYSE and commence delisting proceedings with respect to such securities. …”see in full comparison
“On November 14, 2023, to document the deposits by the Sponsor into the Trust Account in connection with the implementation of the Second Extension Amendment Proposal, we issued the Extension Note in the aggregate principal amount of up to $450,000 to the Sponsor. …”see in full comparison
In connection with the Company’s assessment of going concern considerations in accordance with ASC 205-40, “Presentation of Financial Statements - Going Concern,” we have until September 16, 2026 to consummatesee in full comparisonthe Proposed Business Combination or another Initial Business Combination. On September 15, 2023, the Company’s shareholders voted to extend the date by which the Company has to consummatean Initial Business Combinationfrom September 16, 2023 to March 16, 2024 or such later date by which the Company must complete an Initial Business Combination pursuant to an amendment to the Company’s Charter. On March 6, 2023, the Company’s shareholders voted to extend the date by which the Company has to consummate an Initial Business Combination from March 16, 2024 to September 16, 2024or such later date by which the Company must complete anInitial Business Combination pursuant to an amendment to the Company’sCharter. On September 16, 2024, the Company’s shareholders voted to extend the date by which the Company has to consummate an Initial Business Combination from September 16, 2024 to March 16, 2026 or such later date by which the Company must complete an Initial Business Combination pursuant to an amendment to the Company’s Charter. On March 16, 2026, the Company’s shareholders voted to extend the date by which the Company has to consummate an Initial Business Combination from March 16, 2026 to September 16, 2026 or such later date by which the Company must complete anInitial Business Combination pursuant to an amendment to the Company’sCharter.Amended and Restated Memorandum and Articles of Association. It is uncertain that we will be able to consummatethe Proposed Business Combination or anotheran Initial Business Combination by September 16, 2026. Additionally, we may not have sufficient liquidity to fund our working capital needs until one year from the issuance of these consolidated financial statements. Ifthe Proposed Business Combination or anotheran Initial Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and mandatory liquidation, shouldthe Proposed Business Combination or anotheran Initial Business Combination not occur, and potential subsequent dissolution, raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after September 16, 2026.
“On November 14, 2023, to document the deposits by the Sponsor into the Trust Account in connection with the implementation of the Second Extension Amendment Proposal, the Company issued the Extension Note in the aggregate principal amount of up to $450,000 to the Sponsor. As of March 16, 2024, the Sponsor had deposited the maximum contribution of $450,000. Pursuant to the Member Agreement, the amounts owed to the Sponsor under the Extension Note were forgiven. …”see in full comparison
“On October 6, 2025, we, Holdco, Holdco Merger Sub, Acquiror Merger Sub, and iRocket entered into Merger Agreement Amendment 1, pursuant to which Section 7.07 of the Merger Agreement was amended to extend the deadline for the Company to file its Multi-Year 10-K from October 6, 2025 to October 31, 2025. …”see in full comparison
Full comparison: every changed paragraph (28)
On
July 22, 2025, we entered
into the Merger Agreement, with Holdco,Innovative HoldcoRocket MergerTechnologies Sub,Inc. Acquiror Merger Sub, and iRocket.(“iRocket”). For additional
information see “Item
1. Business—Proposed Business Combination with iRocket” of the Company’s Annual Report
on Form 10-K filed with the SEC
on November 28, 2025, as amended in January 2026, the Company’s Current Report on Form 8-K filed
with the SEC on July 23, 2025 and
the Company’sCompany Current Report on Form 8-K filed with the SEC on June 25, 2026.
On
October 6, 2025, we, Holdco, Holdco Merger Sub, Acquiror Merger Sub, and iRocket entered into Merger Agreement Amendment 1, pursuant
to which Section 7.07 of the Merger Agreement was amended to extend the deadline for the Company to file its Multi-Year 10-K from October
6, 2025 to October 31, 2025. On October 30, 2025, we, Holdco, Holdco Merger Sub, Acquiror Merger Sub, and iRocket entered Merger Agreement
Amendment 2, pursuant to which Section 7.07 of the Merger Agreement was amended to extend the deadline for the Company to file its Multi-Year
10-K from October 31, 2025 to November 30, 2025. On December 12, 2025, we, Holdco, Holdco Merger Sub, Acquiror Merger Sub, and iRocket
entered into Merger Agreement Amendment 3, pursuant to which Section 7.06(a) of the Merger Agreement was amended to extend the deadline
for the Company’s securities to be qualified for quotation on the OTC Markets Group from ten (10) Business Days following the filing
of the Multi-Year 10-K to December 31, 2025, or such later date as mutually agreed in writing by the Company and iRocket.
On
March 13, 2023, we held
the First Extension Meeting. At the First Extension Meeting, our shareholders approved as a special resolution,
the amendment of our CharterAmended
and Restated Memorandum and Articles of Association to extend the date by which we must complete an Initial Business Combination by up
to six months in one-month
increments subject to deposit of $165,000 into the Trust Account for each month by which such date is extended.
In connection with the
vote to approve the First Extension Amendment Proposal, the holders of 28,119,098 Public Shares properly exercised
their right to redeem
their Public Shares for cash at a redemption price of approximately $10.23 per share, for an aggregate redemption
amount of approximately
$287.7 million. Between March 31, 2023 and August 16, 2023, APRINOIA made monthly deposits of $165,000 ($990,000
in the aggregate) to
the Trust Account pursuant to an advance agreement. Under the First Extension, the date by which we must complete
an Initial Business
Combination was extended from March 16, 2023 to September 16, 2023. The balance under the advance agreement was extinguished
pursuant pursuant
to the Termination Agreement.
On
September 15, 2023, we
held the Second Extension Meeting. At the Second Extension Meeting, our shareholders approved as a special resolution,
the amendment of
our CharterAmended and Restated Memorandum and Articles of Association to extend the date by which we must complete an Initial Business Combination
by up to six months in one-month
increments subject to deposit of $75,000 into the Trust Account for each month by which such date was
extended. In connection with the
vote to approve the Second Extension Amendment Proposal, the holders of 1,339,804 Public Shares properly
exercised their right to redeem
their shares for cash at a redemption price of approximately $10.74 per share, for an aggregate redemption
amount of approximately $14.4
million. Between September 18, 2023 and February 21, 2024, the Sponsor made monthly deposits of $75,000
($450,000 in the aggregate) to
the Trust Account, which deposits by the Sponsor into the Trust Account were documented by the Extension
Note in the aggregate principal
amount of up to $450,000 to the Sponsor. Under the Second Extension, the date by which we must complete
an Initial Business Combination
was extended from September 16, 2023 to March 16, 2024. Pursuant to the Member Agreement, the amounts
owed to the Sponsor under the Extension
Note were forgiven.
On
March 6, 2024, we held
the Third Extension Meeting. At the Third Extension Meeting, our shareholders approved as a special resolution,
the amendment of our CharterAmended
and Restated Memorandum and Articles of Association to extend the date by which we must complete an Initial Business Combination by up
to six months in one-month
increments subject to deposit of an amount equal to the lesser of (i) $0.03 per Public Share that was not submitted
for redemption and
(ii) an aggregate of $90,000. In connection with the vote to approve the Third Extension Amendment Proposal, the holders
of 2,372,565
Public Shares properly exercised their right to redeem their Public Shares for cash at a redemption price of approximately
$11.02 per
share, for an aggregate redemption amount of approximately $26.2 million. Between March 16, 2024 and September 26, 2024, the
Contributors Contributors
made monthly deposits of $80,055.99 ($480,335.94 in the aggregate) to the Trust Account, which deposits were in the form
of non-interest
bearing loans. Under the Third Extension, the date by which we must complete an Initial Business Combination was extended
from March
16, 2024 to September 16, 2024. Pursuant to the Member Agreement, the amounts owed to the Contributors for the non-interest
bearing loans
in connection with the Third Extension were forgiven.
The Company has called an extraordinary general meeting of shareholders (the “Sixth Extension Meeting”) to, among other things, consider, and if thought fit, approve a proposal to amend the Company’s Amended and Restated Memorandum and Articles of Association to extend the date by which the Company has to consummate an Initial Business Combination from September 16, 2026 to March 16, 2028. The Sixth Extension Meeting is scheduled for September 16, 2026 at 10:00 a.m. Eastern Time at the office of White & Case LLP at 1221 Avenue of the Americas, New York, NY 10020, and via a virtual meeting at www.virtualshareholdermeeting.com/BPGC2026SM2, or at such other time, on such other date and at such other place to which the extraordinary general meeting may be adjourned. For additional information on the Sixth Extension Meeting, see the Company’s proxy statement filed with the SEC on August 17, 2026.
On November 14, 2023, we issued the Extension Note in the aggregate principal amount of up to $450,000 to the Sponsor. As of March 16, 2024, the Sponsor had deposited the maximum contribution of $450,000. Pursuant to the Member Agreement, the amounts owed to the Sponsor under the Extension Note were forgiven and recorded as a capital contribution.
On
November 14, 2023, to document the deposits by the Sponsor into the Trust Account in connection with the implementation of the Second
Extension Amendment Proposal, we issued the Extension Note in the aggregate principal amount of up to $450,000 to the Sponsor. Pursuant
to the Extension Note, and in connection with the implementation of the Second Extension Amendment Proposal, the Sponsor was permitted,
but not obligated to, deposit $75,000 for each calendar month (commencing on September 16, 2023 and ending on the 15th day
of each subsequent month), or portion thereof, that is needed by us to complete an Initial Business Combination until March 16, 2024,
resulting in a maximum extension payment of $450,000. As of March 16, 2024, the Sponsor had deposited the maximum contribution of $450,000.
Pursuant to the Member Agreement, the amounts owed to the Sponsor under the Extension Note were forgiven. Before such amounts were forgiven,
we were to repay the Extension Note out of the proceeds of the Trust Account released to us and other proceeds of the transaction if
we completed an Initial Business Combination. In the event that we did not complete an Initial Business Combination, we were to be permitted
to use a portion of the proceeds held outside the Trust Account to repay the Extension Note but no proceeds held in the Trust Account
were to be used to repay the Extension Note. . As of March 31, 2026 and December 31, 2025, we had borrowings of $450,000 for extension
payments, of which has since been forgiven and recorded as capital contribution.
In
connection with the Third Extension, Between March 16, 2024 and
September 26, 2024, the Contributors made monthly deposits of $80,056
($480,336 in the aggregate) to the Trust Account, which deposits
were in the form of non-interest bearing loans. Pursuant to the Member
Agreement, the amounts owed to the Contributors for the non-interest
bearing loans in connection with the Third Extension were forgiven.
Before such amounts were forgiven, we were to repay such loans out of the proceeds of the Trust Account released to us and other proceeds
of the transaction if we completed an Initial Business Combination. In the event that we did not complete an Initial Business Combination,
we were to be permitted to use a portion of the proceeds held outside the Trust Account to repay such loans but no proceeds held in the
Trust Account were to be used to repay such loans.
Our
management has broad
discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale
of Private Placement
Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating
the Proposed Business Combination or anotheran Initial Business
Combination. However, we will only complete the Proposed Business Combination
or anotheran Initial Business Combination if the post-transaction company owns or acquires 50% or more
of the outstanding voting securities
of the target business or otherwise acquires a controlling interest in the target business sufficient
for it not to be required to register
as an investment company under the Investment Company Act.
If
we are unable to complete the Proposed Business Combination or
an Initial Business Combination by September 16, 2026 or such later date
by which we must complete the Proposed Business Combination or anotheran Initial Business Combination pursuant
to an amendment to our Charter,
Amended and Restated Memorandum and Articles of Association, we will (i) cease all operations except for the purpose
of winding up; (ii) as promptly as reasonably possible but not more than ten
business days thereafter, redeem the Public Shares, at a
per-share price, payable in cash, equal to the aggregate amount then on deposit
in the Trust Account, including interest earned on the
funds held in the Trust Account and not previously released to us to pay our tax
obligations, if any (less taxes payable and up to $100,000
of interest to pay dissolution expenses) divided by the number of the then-outstanding
Public Shares, which redemption will completely
extinguish Public Shareholders’ rights as shareholders (including the right to
receive further liquidation distributions, if any);
and (iii) as promptly as reasonably possible following such redemption, subject to
the approval of the remaining shareholders and the
board of directors, liquidate and dissolve, subject in the case of clauses (ii) and
(iii), to our obligations under Cayman Islands law
to provide for claims of creditors and the requirements of other applicable law.
Delisting
from NYSE
On
March 18, 2024, the Company received notice from the NYSE informing us that it would suspend the listing of the Company’s securities,
including the Class A Ordinary Shares, Warrants and Units, from the NYSE and commence delisting proceedings with respect to such securities.
The NYSE determined to take these actions because Sections 102.06e and 802.01B of the NYSE’s Listed Company Manual do not permit
a special purpose acquisition company, such as the Company, to remain listed for more than three years after the company’s initial
public offering without completing an initial business combination. The Company had not completed its Initial Business Combination before
March 16, 2024, which was the three-year anniversary of the Initial Public Offering. On April 3, 2024, the NYSE notified the SEC that
the Company’s securities would be delisted from the exchange effective April 15, 2024.
As
of MarchJune 31,30, 2026, we had
$0 in our operating bank account and working capital deficit of $4,691,506.$4,793,836.
Our
liquidity needs through
June March 31,30, 2026 and prior were satisfied through a payment of $25,000 from the Sponsor to purchase certain expenses
in exchange for the
issuance of the Founder Shares, the loan of approximately $90,000 from the Sponsor under the IPO Promissory Note
and the proceeds from
the consummation of the Private Placement not held in the Trust Account. We repaid the IPO Promissory Note in full
on March 19, 2021.
On November 14, 2023, the Company issued the Extension Note in the aggregate principal amount of up to $450,000 to the Sponsor. As of March 16, 2024, the Sponsor had deposited the maximum contribution of $450,000. Pursuant to the Member Agreement, the amounts owed to the Sponsor under the Extension Note were forgiven and recorded as capital contribution.
On
November 14, 2023, to document the deposits by the Sponsor into the Trust Account in connection with the implementation of the Second
Extension Amendment Proposal, the Company issued the Extension Note in the aggregate principal amount of up to $450,000 to the Sponsor.
As of March 16, 2024, the Sponsor had deposited the maximum contribution of $450,000. Pursuant to the Member Agreement, the amounts owed
to the Sponsor under the Extension Note were forgiven. Before such amounts were forgiven, we were to repay the Extension Note out of
the proceeds of the Trust Account released to us and other proceeds of the transaction if we completed an Initial Business Combination.
In the event that we did not complete an Initial Business Combination, we were to be permitted to use a portion of the proceeds held
outside the Trust Account to repay the Extension Note but no proceeds held in the Trust Account were to be used to repay the Extension
Note. As of March 31, 2026 and December 31, 2025, we had borrowings of $450,000 for extension payments, of which has since been forgiven
and recorded as capital contribution.
On
November 14, 2023, to
document existing and future Working Capital Loans, the Company issued the Convertible Note, an unsecured, convertible
promissory note,
to the Sponsor, pursuant to which the Company can borrow up to $1,500,000 from the Sponsor, for ongoing expenses reasonably
related to
the business of the Company and the consummation of an Initial Business Combination. All unpaid principal under the Convertible
Note will
be due and payable in full on the Maturity Date, which is the earlier of (i) September 16, 2026, or such later date by which
the Company
must consummate an Initial Business Combination pursuant to its CharterAmended and Restated Memorandum and Articles of Association (as may be
amended by shareholder vote) and (ii)
the effective date of an Initial Business Combination. The Sponsor has the option, at any time on
or prior to the Maturity Date, to convert
any amounts outstanding under the Convertible Note, up to an aggregate amount of $1,500,000,
into Warrants to purchase Class A Ordinary
Shares of the Company, at a conversion price of $1.50 per Warrant, with each Warrant entitling
the holder to purchase one Class A Ordinary
Share at a price of $11.50 per share, subject to the same adjustments applicable to the Private
Placement Warrants sold concurrently
with the Company’s Initial Public Offering. As of MarchJune 31,30, 2026 and December 31, 2025, the
Company had borrowed $0, from the Sponsor
under the Convertible Note. If the Company completes the Proposed Business Combination or anotheran Initial Business Combination, the Company
will repay the Convertible Note out of the proceeds of the Trust Account released to the Company (unless the Sponsor elects to convert
the outstanding balance into Warrants or other arrangements are made). In the event that thean Proposed Business Combination or another
Initial Business Combination does not close,
the Company may use a portion of the proceeds held outside the Trust Account to repay the
Convertible Note but no proceeds held in the
Trust Account would be used to repay the Convertible Note.
In
connection with the Third
Extension, Betweenbetween March 16, 2024 and September 26, 2024, certain members of the Sponsor (collectively, the “Contributors ”)
made monthly deposits of $80,056
($480,336 in the aggregate) to the Trust Account, which deposits were in the form of non-interest bearing
loans. Pursuant to the Member
Agreement, the amounts owed to the Contributors for the non-interest bearing loans in connection with the
Third Extension were forgiven.
Before such amounts were forgiven, we were to repay such loans out of the proceeds of the Trust Account released to us and other proceeds
of the transaction if we completed an Initial Business Combination. In the event that we did not complete an Initial Business Combination,
we were to be permitted to use a portion of the proceeds held outside the Trust Account to repay such loans but no proceeds held in the
Trust Account were to be used to repay such loans.
In
addition, in order to
finance transactionworking costscapital, in connection with the Proposed Business Combination or another Initial Business Combination,
the Sponsor or an affiliate of the Sponsor, or certain of our officers and directors may, but are not obligated
to, provide the Company
with additional Working Capital Loans.
In
connection with the Company’s
assessment of going concern considerations in accordance with ASC 205-40, “Presentation of
Financial Statements - Going Concern,”
we have until September 16, 2026 to consummate the Proposed Business Combination or another
Initial Business Combination. On September 15, 2023, the Company’s shareholders voted to extend the date by which the Company has
to consummate an Initial Business Combination from September 16, 2023 to March 16, 2024 or such later date by which the Company must
complete an Initial Business Combination pursuant to an amendment to the Company’s Charter. On March 6, 2023, the Company’s
shareholders voted to extend the date by which the Company has to consummate an Initial Business Combination from March 16, 2024 to September
16, 2024 or such later date by which the Company must complete an Initial Business Combination pursuant to an amendment to the Company’s
Charter. On September 16, 2024, the Company’s shareholders voted to extend the date by which the Company has to consummate an Initial
Business Combination from September 16, 2024 to March 16, 2026 or such later date by which the Company must complete an Initial Business
Combination pursuant to an amendment to the Company’s Charter. On March 16, 2026, the Company’s shareholders voted to extend
the date by which the Company has to consummate an Initial Business Combination from March 16, 2026 to September 16, 2026 or such later
date by which the Company must complete an Initial Business Combination pursuant to an amendment to the Company’s Charter.Amended and Restated Memorandum and Articles of Association.
It is
uncertain that we will be able to consummate the Proposed Business Combination or anotheran Initial Business Combination by September 16,
2026. Additionally, we may not have
sufficient liquidity to fund our working capital needs until one year from the issuance of these
consolidated financial statements. If the Proposed Business Combination or another
an Initial Business Combination is not consummated by
this date, there will be a mandatory liquidation and subsequent dissolution of the
Company. Management has determined that the liquidity
condition and mandatory liquidation, should the Proposed Business Combination or anotheran Initial Business Combination not
occur, and
potential subsequent dissolution, raises substantial doubt about the Company’s ability to continue as a going concern.
No adjustments
have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after September
16, 2026.
Our
entire activity from
inception to MarchJune 31,30, 2026 was in preparation for our formation and the Initial Public Offering, and, subsequent
to the Initial Public
Offering, identifying a target company for an Initial Business Combination,Combination. including the Proposed Business Combination.
We will not be generating any operating revenues until the
closing and completion of the Proposed Business Combination or anotheran Initial
Business Combination, at the earliest.
For
the three months ended
June March 31,30, 2026, we had net income of $2,170,518,$5,718,020, which consisted of $2,305,510 in non-operating gain resulting
from thea change in fair value of derivative warrant liabilities,liabilities $10,931of $5,812,113
and $8,237 of income from investments held in the Trust AccountAccount, partially
offset by,by $145,923$102,330 in general and administrative expenses.
For
the threesix months ended
June March30, 31, 2025,2026, we had net lossincome of $3,400,$7,888,538, which consisted of $15,445 in general and administrative expenses,
$2,300$8,117,623 in non-operating lossgain resulting from the change in fair
value of derivative warrant liabilities, partially offset by $14,345$19,168 of
income from investments held in the Trust Account.Account partially offset by, $248,253 in
general and administrative expenses.
For the three months ended June 30, 2025, we had net loss of $6,422,831, which consisted of $5,281,470 in non-operating loss resulting from the change in fair value of derivative warrant liabilities and $1,155,981 in general and administrative expenses, partially offset by $14,620 of income from investments held in the Trust Account.
For the three months ended June 30, 2025, we had net loss of $6,426,231, which consisted of $5,283,770 in non-operating loss resulting from the change in fair value of derivative warrant liabilities and $1,171,426 in general and administrative expenses, partially offset by $28,965 of income from investments held in the Trust Account.
The
Public Warrants and the
Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly,
the Company recognizes the
Warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair
value at each reporting period
until they are exercised. The initial fair value of the Public Warrants and the Private Placement Warrants issued in connection with the Initial
Initial Public Offering were estimated using a Lattice modelmodel. and the Private Placement Warrants were estimated using a Lattice model.
The fair value of the Public Warrants as of December 31, 2023 and 2022 is based on observable listed prices for such Public Warrants.
As the transfer of Private Placement Warrants to anyone who is not a permitted transferee
would result in the Private Placement Warrants
having substantially the same terms as the Public Warrants, the Company determined that
the fair value of each Private Placement Warrant
is equivalent to that of each Public Warrant as of MarchJune 31,30, 2026 and December 31, 2025.
The fair value of the Public Warrants as of
March 31,June 30, 2026 and December 31, 2025 using the lattice model. The determination of the fair
value of the Warrant liability may be subject
to change as more current information becomes available and accordingly the actual results
could differ significantly. Derivative Warrant
liabilities are classified as non-current liabilities as their liquidation is not reasonably
expected to require the use of current assets
or require the creation of current liabilities.
As
of MarchJune 31,30, 2026 and December
31, 2025, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation
S-K.
ROSS insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding ROSS (13F)
None of the 59 investors we track reported a position in their latest 13F.